Eikon Therapeutics Inc. Common Stock

EIKN | NASDAQ

$5.31

-$0.04 (-0.75%)

At close: Oct 30, 2026, 4:00 PM ET

$5.20

-$0.11 (-2.07%)

Pre-market: Nov 2, 2026, 6:37 AM ET

TTM Period Ending	TTM 2026 Jun 30, 2026	TTM 2026 Mar 31, 2026	TTM 2025 Dec 31, 2025
PE Ratio	-2.82	-3.53	-2.44
PEG Ratio	-0.43	-0.86	n/a
PS Ratio	n/a	n/a	n/a
PB Ratio	1.51	1.04	-0.92
P/FCF Ratio	-2.73	-2.95	-3.45
P/OCF Ratio	-2.76	-3	-4.31
OCF/S Ratio	n/a	n/a	n/a
Debt / Equity Ratio	0.54	0.46	-0.29
Quick Ratio	9.89	11.75	6.34
Current Ratio	9.89	11.75	6.34
Asset Turnover	n/a	n/a	n/a
Interest Coverage	n/a	n/a	-404.95
Return on Equity	-16.11%	2.84%	36.89%
Return on Assets	-41.33%	-27.47%	-54.52%
Return on Invested Capital	-37.22%	-24.05%	-61.65%
Dividend Yield	n/a	n/a	n/a
Payout Ratio	n/a	n/a	n/a
FCF Payout Ratio	n/a	n/a	n/a
Gross Profit Margin	n/a	n/a	n/a
Net Profit Margin	n/a	n/a	n/a
Pretax Profit Margin	n/a	n/a	n/a
Operating Profit Margin	n/a	n/a	n/a
FCF Margin	n/a	n/a	n/a
EBITDA Margin	n/a	n/a	n/a